ArticleCancer immunology, immunotherapy : CII2023

Functional enhancement of mesothelin-targeted TRuC-T cells by a PD1-CD28 chimeric switch receptor.

Derrick McCarthy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.